Operational Usability Evaluation of the LIAISON® QuantiFERON®-TB Gold Plus Solution in a High Volume Laboratory Setting
Related Experiment Video
Updated: Nov 30, 2025
08:54
Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
Published on: May 19, 2020
8.0K
Clinical Laboratory
|November 12, 2020
Abstract
Background:
Screening for latent tuberculosis infection (LTBI) using interferon gamma release assays has become commonplace for a variety of reasons. Given the high test volume, automated platforms are highly desired.
Methods:
To this end, we performed an operational usability study using a newly FDA-approved, fully automated, random-access platform.
Results & Conclusions:
Our results showed that this platform can save time and labor and will be a potential useful addition to streamline LTBI screening. Studies to verify performance characteristics are warranted.
